Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease

ISSN： 1170-229X

Source： Drugs & Aging, Vol.15, Iss.2, 1999-08, pp. : 91-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

By Colwell John A.

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Use of β-Adrenoceptor Antagonists in Older Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Co-Morbidity: Safety Issues

By Andrus Miranda R. Loyed Joyce V.

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 131-144

Adis International

Access to resources Recommend Favorite

Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 850-860

Bentham Science Publishers

Access to resources Recommend Favorite

Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease

Current Medicinal Chemistry, Vol. 19, Iss. 24, 2012-08 ,pp. : 4175-4183

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Lowering for Secondary Prevention of Cardiovascular Disease in Older Adults

By Thomas Joseph E.

Drugs & Aging, Vol. 27, Iss. 12, 2010-12 ,pp. : 959-972

Adis International

Access to resources Recommend Favorite